References - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/21736/15/15_bibliography.pdf · References 152 prefrontal cortex and amygdala. Behav.Brain Res 2009; 203(2): 279-287

References

151

Adenusi AA Odaibo AB Laboratory assessment of molluscicidal activity of crude

aqueous and ethanolic extracts of Dalbergia sissoo plant parts against Biomphalaria

pfeifferi Travel Med Infect Dis 2008 6(4) 219-27

Agosta W Medicines and Drugs from Plants Journal of Chemical Education 1997 74

857

Aiyeloja AA Bello OA Ethnobotanical potentials of common herbs in Nigeria A case

study of Enugu state Educational Research and Review 2006 1(1) 16-22

Ajaiyeoba EO Oladepo O Fawole OI Balaji OM Akinboye DO Ogundahunsi OA et al

Cultural categorization of febrile illeness in co-relation with herbal remedies used for the

treatment in Southwestern Nigeria Journal of Ethnopharmacology 2003 85 179-185

Akhondzadeh S Naghavi HR Vazirian M Shayeganpour A Rashidi H Khani M

Passionflower in the treatment of generalized anxiety A pilot double-blind randomized

controlled trial with oxazepam Journal of Clinical Pharmacy ampTherapeutics 2001 26

363-367

Alam MK Mohiuddin M Guha MK Trees for low lying areas of Bangladesh Bangladesh

Forest Research Institute Chittagong 2001 98

Ali AAN Al-rahwi K Lindequist U Some medicinal plants used in Yemeni herbs

medicine to treat Malaria African Journal of Traditional Complementary and Alternative

Medicines 2004 1 72-76

Alldredge B Pathogenic involvement of neuropeptides in anxiety and depression

Neuropeptides 2010 44(3) 215-224

Almada RC Borelli KG Brechet-Souza L Brandao ML Serotonergic mechanisms of the

median raphe nucleus-dorsal hippocampus in conditioned fear Output circuit involves the

References

152

prefrontal cortex and amygdala BehavBrain Res 2009 203(2) 279-287

Aloisi AM Ceccarelli I Masi F Scaramuzzino A Effects of the essential oil from Citrus

limon in male and female rats exposed to a persistent painful stimulation Behavioural

Brain Research 2002 136 127-135

Alonso J and Lepine JP Overview of key data from the European Study of the

Epidemiology of Mental Disorders Journal of Clinical Psychiatry 2007 68 3-9

Amolkar HK Archana JR Effect of alkaloidal fraction of Elaeocarpus ganitrus seeds on

murine in vitroimmune parameters Journal of Pharmacy Research 2009 2(7) 1261-1265

Amsterdam JD Li Y Soeller I Rockwell K Mao JJ Shults J A randomized doubleblind

placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for

generalized anxiety disorder Journal of Clinical Psychopharmacology 2009 29 378-382

Anonymous The Wealth of India A dictionary for Indian raw material and industrial

products ndash Raw Materials (CSIR New Delhi) National Institute of Science

Communication New Delhi India 1950 3



Communication New Delhi India 1992 3 609-678

Anonymous The Wealth of India A dictionary of Indian raw materials and industrial

product first supplement series D-I (Raw Materials) National Institute of Science

Communication New Delhi India 2001 3 58

Ansari MA Razdan RK Tandon M Vasudeva P Larvicidal and reppellant actions of

Dalbergis sisso Roxb (Family Leguminasae) oil against mosquitoes Bioresource Tech

2010 73(3) 207-211

References

153

Ardayfio P and Kim KS Anxiogenic-like effect of chronic corticosterone in the light-dark

emergence task in mice Behav Neurosci 2006 120 249-256

Arias BA and Laca LR Pharmacological properties of Citrus and their ancient and

Medieval uses in the Mediterranean region Journal of Ethnopharmacology 2005 97 89-

95

Asaad Aya M El-Shaer Nagwa S Darwish F Flavonoids from Dalbergia sissoo Roxb

cultivated in Egypt Alexandria Journal of Pharmaceutical Sciences2000 14 103ndash105

Asif M and Kumar AJ Phytochemical investigation and evaluation of antinociceptive

activity of ethanolic extract of Dalbergia sissoo (Roxb) bark Nat Sci Biol Med 2011

2(1) 76-79

Asolkar LV Kakkar RR Chakre OJ In Second Supplement to Glossary of Indian

Medicinal Plants with Active Principles Part I (1965ndash1981) PID amp CSIR New Delhi

India 1992 289

Atal CK and Kapur BM Use of essential oils In Cultivation and Utilization of Aromatic

Plants Regional Research Laboratory Jammu-Tawi 1989 747

Avallone R Zanoli P Puia G Kleinschnitz M Schreier P Baraldi M Pharmacological

profile of apigenin a flavonoid isolated from Matricaria chamomilla Biochemical

Pharmacology 2000 59 1387-1394

Bairagi GB Kabra AO Mandade RJ Anthelmintic activity of Citrus limon l (burm) peels

extract in Indian adult earthworm International Journal of Pharmacy amp Technology 2011

3(1) 1913-1919

Baker J Borris R Carte B Cordell G Soejarto D Cragg G Gupta M Iwu M Madulid D

Tyler V Natural product drug discovery and development new perspectives on

References

154

International collaboration Journal of Natural Products 1995 58 1325-1357

Baldwin DS and Polkinghorn C Evidence-based pharmacotherapy of Generalized Anxiety

Disorder Int J Neuropsychopharmacol 2005 8(2) 293-302

Balick MJ and Cox PA Plant People and Culture New York USA Scientific American

Library New York 1997

Balunas MJ and Kinghorn AD Drug discovery from medicinal plants Life science 2005

78 431-441

Banerjee A Murti VVS Sheshadri TR Isolation of sissotrin a new isoflavone glycoside

from the leaves of Dalbergia sissoo Indian Journal of Chemistry 1966 4 70ndash72

Baquar SR Medical and poisonous plants of Pakistan Printas Karachi Pakistan 1989

506

Barchas JD Altemus M Biochemical hypotheses of Mood and Anxiety Disorders In

Siegel GJ Agranoff BW Albers RW Fischer SK Uhler MD (eds) Basic neurochemistry

molecular cellular and medical aspects Philadelphia Lipincott-Raven Publishers 1999

1073-1093

Barker P Psychiatric and mental health nursing the craft of caring London Arnold 2003

Barrett JE and Vanover KE 5-HT receptors as targets for the development of novel

anxiolytic drugs models mechanisms and future directions Psychopharmacology (Berl)

1993 112(1) 1-12

Beaubrun G and Gray GE A review of herbal medicines for psychiatric disorders

Psychiatric Services 2000 51 1130-1134

Bedard T Mountney C Kent P Anisman H Merali Z Role of gastrin-releasing peptide

and neuromedin B in anxiety and fear-related behavior BehavBrain Res 2007 179 (1)

References

155

133-140

Benke D Barberis A Kopp S Altmann KH Schubiger M Vogt KE Rudolph U Mohler

H GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid a

major constituent of valerian root extracts Neuropharmacology 2009 56 174-181

Berkarda B Koyuncu H Soyabir G Baykut F Inhibitory effect of hesperidin on tumour

initiation and promotion in mouse skin Research in Experimental Medicine 1998 198 93-

99

Berqvist D Hallbrook T Lindblad B Lindhagen A A double blind trail of O-(α-hydroxy

ethyl)-rutinosides in patients with chronic venous insufficiency Vasa 1981 10 253-260

Beuzen A and Belzung C Link between emotional memory and anxiety states A study by

principal component analysis Physiol Behav 1995 58 111ndash118

Bhattacharjee SK In Handbook of Medicinal plants Pointeer Publishers Jaipur 101-102

1998

Bhattacharya SK Debnath PK Pandey VB Sanyal AK Pharmacological investigations on

Elaeocarpus ganitrus Planta Medica 1975 28(6) 174-176

Bhattamisra SK Singh PN Singh SK Kumar V Anxiolytic activity of Marsileaminuta

Linn in rodents Journal of Herbal Medicine and Toxicology 2007 1(1) 15-20

Birdsall TC 5-Hydroxytryptophan a clinically-effective serotonin precursor Altern Med

Rev 1998 3(4) 271-280

Blanco E Castilla-Ortega E Miranda R Begega A Aguirre JA Arias JL Santin LJ

Effects of medial prefrontal cortex lesions on anxiety-like behaviour in restrained and non-

restrained rats Behav Brain Res 2009 201(2) 338-342

Blaskovich MA Sun J Cantor A Turkson J Jove R Sebti SM Discovery of JSI-124

References

156

(Cucurbitacin-I) A selective Janus kinasesignal transducer and activator of transcription

3 signaling pathway inhibitor with potent antitumor activity against human and murine

cancer cells in mice Can Res 2003 63 1270-1279

Blumental M Goldberg A Brinckmann J Herbal Medicine Expanded Commission

Monographs Newton MA (eds) Integrative Medicine Communications 2000 293

Boerner RJ Sommer H Berger W Kuhn U Schmidt U Mannel M Kava-Kava extract LI

150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-

week randomized double-blind multi-centre clinical trial in 129 outpatients

Phytomedicine 2003 10 38-49

Bogdanski DF PletscherA Brodie BB Udenfriend S Identification and assay of serotonin

in brain J Pharmacol Exp Ther 1956 117(1) 82ndash88

Bonfil RD Russo DM Binda MM Delgado FM Vincenti M Higher antitumor activity of

vinflunine than vinorelbine against an orthotopic murinemodel of transitional cell

carcinoma of the bladder Uro Onco 2002 7 159-166

Bourin M and Hascoet M The mouse lightdark box test European Journal of

Pharmacology 2003 463(1-3) 55-65

Bourin M and Hascoet M The mouse lightdark box test Eur J Pharmacol 2003 463(1-

3) 55-65

Bourin M Animal models of anxiety are they suitable for predicting drug action in

humans Pol J Pharmacol 1997 49 79ndash84

Bourin M Petit-Demouliegravere B Nic Dhonnchadha BA Hascoet M Animal models of

anxiety in mice Fundam Clin Pharmacol 2007 21 567ndash574

Brijesh S Daswani PG Tetali P Antia NH Birdi TJ Studies on Dalbergia sissoo (Roxb)

References

157

leaves Possible mechanism(s) of action in infectious diarrhea Indian J Pharmacol 2006

38(2) 120-124

Briskin DP Medicinal plants and phytomedicines - linking plant biochemistry and

physiology to human health Plant Physiology 2000 124 507-514

Browne FG Pests and diseases of forest plantations trees Clarendon press oxford1968

1330

Bruner NR and Anderson KG Discriminative stimulus and time-course effects of kava

kava (Piper methysticum) in rats Pharmacology Biochemistry amp Behavior 2009 92 297-

303

Buckheit J RW White EL Fliakas-Boltz V Russell J Stup TL Kinjerski TL Osterling

MC Weigand A Bader JP Unique anti-human immune deficiency virus activities of the

nonnucleoside reverse transcriptaseinhibitors calanolide A costatolide and

dihydrocostatolide Antimicrob agents Chemother 1999 431827-1834

Butler MS The role of natural product chemistry in drug discovery J NatProd 2004 67

2141-2153

Butterweck V Schmidt M St Johns wort role of active compounds for its mechanism of

action and efficacy Wien Med Wochenschr 2007 157 356-361

Cadieux RJ Azapirones an alternative to benzodiazepines for anxiety Am Fam Physician

1996 53 2349-2353

Calabrese V Scapagnini G Randazzo SD Randazzo G Catalano C Geraci G Morganti

P Oxidative stress and antioxidants at skin biosurface a novel antioxidant from lemon oil

capable of inhibiting oxidative damage to the skin Drugs under Experimental and Clinical

Research 1999 25 281-287

References

158

Campagna-Slater V Weaver DF Molecular modelling of the GABAA ion channel protein

J Mol Graph Model 2007 25(5) 721-730

Campeau S Davis M Involvement of the central nucleus and basolateral complex of the

amygdala in fear conditioning measured with fear-potentiated startle in rats trained

concurrently with auditory and visual conditioned stimuli J Neurosci 1995 15 2301-

2311

Campelo LML Antonia AC Almeida D Mendes RL Freitas D Cerqueira DS Sousa

GLD Saldanha GBFeitosa CM Freitas RMD Antioxidant and Antinociceptive Effects of

Citrus limon Essential Oil in Mice Journal of Biomedicine and Biotechnology 2011 1- 8

Cannell R JP Natural Products Isolation New Jersey Human Press Inc 1998 165ndash208

Canteras NS Resstel LB Bertoglio LJ Carobrez AP Guimaraes FS Neuroanatomy of

anxiety Curr Top Behav Neurosci 2010 2 77-96

Carlini EA Plants and the central nervous system Pharmacology Biochemistry and

Behavior 2003 75 501-512

Carobrez AP Bertoglio LJ Ethological and temporal analyses of anxiety-like behavior

The elevated plus-maze model 20 years on Neurosci Biobehav Rev 2005 29(8) 1193-

1205

Chand L Dasgupta S Chattopadhyay SK Ray AB Chemical investigation of some

Elaeocarpus species Planta Medica 1977 32(2) 197-9

Chihiro ITO New cinnamyl phenols from Dalbergia species with cancer chemopreventive

activity J Nat Prod 2003 661574-1577

Chin L Picchioni A Childs R Light-an essential factor in the trihydroxyindole-

spectrophoto fluorometric assay of norepinephrine Journal of Pharmaceutical Science

References

159

1963 52 907-909

Chopin P and Briley M Animal models of anxiety the effect of compounds that modify 5-

HT neurotransmission Trends Pharmacol Sci 1987 8 383-388

Chopra RN Nayer SL Chopra IC Glossary of Indian Medicinal Plants CSIR 1956 New

Delhi 1993 90-91

Cichewicz RH and Kouzi SA Chemistry biological activity and chemotherapeutic

potential of betulinic acid for the prevention and treatment of cancer and HIV infection

Med Res Rev 2004 24 90-114

Clardy J Walsh C Lessons from natural molecules Nature 2004 432 829-837

Clement Y Calatayud F Belzung C Genetic basis of anxiety-like behaviour A critical

review Brain Res Bull 2002 57 57-71

Cloos JM and Ferreira V Current use of benzodiazepines in anxiety disorders Curr Opin

Psychiatry 2009 22(1) 90-95

Connor KM Davidson JR A placebo-controlled study of Kava kava in generalized anxiety

disorder International Clinical Psychopharmacology 2002 17 185-188

Costall B Jones BJ Kelly ME Naylor RJ Tomkins DM Exploration of mice in a black

and white test box validation as a model of anxiety Pharmacol Biochem Behav 1989 32

777ndash785

Costall B and Naylor RJ Anxiolytic effects of 5-HT1antagonists in animals In Rodgers

RJ Cooper RJ (eds) 5-HT1A agonists 5-HT3antagonists and benzodiazepines their

comparative behavioural pharmacology Wiley New York 1991 133-57

Coutinho FC Dias GP Bevilaqua DN Gardino MC Pimentel PF Nardi AE Current

concept of anxiety implications from Darwin to the DSM-V for the diagnosis of

References

160

generalized anxiety disorder ExpertRevNeurother 2010 10(8) 1307-1320

Cox PA and Balick MJ The ethnobotanical approach to drug discovery Sci Am 1994

270 (6) 82-87

Cragg GM and Newman DJ A tale of two tumor targets topoisomerase I andtubulin The

Wall and Wani contribution to cancer chemotherapy JNatProd 2004 67 232-244

Cragg GM Newman DJ Snader KM Natural products in drug discovery and

development J Nat Prod 1997 60(1) 52-60

Crawlet JN Neuropharmacologic specificity of a simple animal model for the behavioral

actions of benzodiazepines Pharmacol Biochem Behav 1981 15 695-699

Crawley J and Goodwin FK Preliminary report of a simple animal behavior model for the

anxiolytic effects of benzodiazepines Pharmacol Biochem Behav 1980 13(2) 167-170

Creagh T Ruckle JL Tolbert DT Giltner J Eiznhamer DA Dutta B Flavin MT Xu ZQ

Safety and pharmacokinetics of single doses of (+)-calanolide A a novel naturally

occurring nonnucleoside reversetranscriptase inhibitor in healthy human

immunodeficiency virus-negativehuman subjects Anti Agen Chemo 2001 45 1379-

1386

Critchley MAE and Handley SL Effects in the Xmazeanxiety model of agents acting at 5-

HT1and 5-HT2 receptors Psychopharmacol (Berl) 1987 93 502-6

Currens MJ Gulakowski RJ Mariner JM Moran RA Buckheit RW Gustafson KR

McMahon JB Boyd MR Antiviral activity andmechanism of action of calanolide A

against the human immune deficiency virus type-1 J Pharm ExpTherapy 1996 279

645-651

Darmon P Flandre O Michel F Perdrix L Labrid C Castres DE Paulet A Effect of

References

161

chronic treatment with a purified flavonoid fraction on inflammatory granuloma in the rat

Study of prostaglandin E2 and F2 a and thromoboxane B2 release and histological changes

Drug Research 1987 37 1149-1153

Davis M and Whalen PJ The amygdala vigilance and emotion MolPsychiatry 2001

613-34

Davis M The role of the amygdala in fear and anxiety Annual Review of Neuroscience

1992 15 353-375

Deckers CL Genton P Sills GJ Schmidt D Current limitations of antiepileptic drug

therapy a conference review Epilepsy Res 2003 53(1-2) 1-17

Denver RJ Structural and functional evolution of vertebrate neuroendocrine stress

systems Ann N Y Acad Sci 2009 11(63) 1-16

Denys D Geus DF Predictors of pharmacotherapy response in anxiety disorders Curr

Psychiatry Rep 2005 7 252-257

Dhawan K Dhawan S Chhabra S Attenuation of benzodiazepine dependence in mice by a

tri-substituted benzoflavone moiety of Passiflora incarnate Linneaus A non-habit forming

anxiolytic Journal of Pharmacy and Pharmaceutical Sciences 2003 6 215-222

Dhawan K Kumar S and Sharma A Comparative anxiolytic activity profile of various

preparations of Passiflora incarnata linneaus a comment on medicinal plants

standardization The Journal of Alternative amp Complementary Medicine 2002 8 283-291

Dhawan K Kumar S Sharma A Anti-anxiety studies on extracts of Passiflora incarnata

Linneaus Journal of Ethnopharmacology 2001 78 165ndash170

Dinan T Therapeutic options Addressing the current dilemma European

Neuropsychopharmacology 2006 16(2) 119-127

References

162

Dixit P Chillara R Khedgikar V Gautam J Kushwaha P Kumar A Singh D Trivedi R

Maurya R Constituents of Dalbergiasissoo Roxb leaves with osteogenic activity Bioorg

Med Chem Lett 2012 22(2) 890-7

Donath F Quispe S Diefenbach K Maurer A Fietze I Roots I Critical evaluation of the

effect of valerian extract on sleep structure and sleep quality Pharmacopsychiatry 2000

33 47-53

Dudai Y Neurobiology Fear thou not Nature 2003 421 325-7

Duke JA Wain KK Medicinal Plants of the WorldFAO Rome Italy 1981 3 277ndash295

Duke JA Dalbergia sissoo Roxb Ex Dc Handbook of energy crops Unpublished

Purdue university Center for new crops amp plant products 1983

Durant C Christmas D Nutt D The pharmacology of anxiety Curr Top Behav Neurosci

2010 2 303-330

Easu K Plant Anatomy John Wiley and Sons New York 1964 767

Ecobichon DJ The basis of Toxicology Testing CRC Press New York 43-861997

Edmond HD and Stroobant V Mass spectrometry Principles and Applications John

Wiley amp Sons Limited Australia 2001

Eisenbrand G Hippe F Jakobs S Muehlbeyer S Molecular mechanisms of indirubin and

its derivatives novel anticancer molecules with their origin in traditional Chinese

phytomedicine J Can Res Clin Onco 2004 130627-635

El-Dagwy AA Encyclopedia for production of aromatic and medicinal plants Vol-I

Imprimerie Atlas Cairo 1996 1 192

El-Din AS El-Sayed K Mahmoud M Effect of ethanolic extract of Dalbergia sissoo plant

parts on Biomphalaria alexandrina snail the intermediate host of Schistosoma mansoni

References

163

Journal of Evolutionary Biology Research 2011 3(7) 95-100

El-hadidi MN Boulos l The street tress of Egypt The American University in Cairo press

Cairo 1988 130

Elndashsheikh MA A study of the vegetation environmental relationships of the canal banks of

the middle delta region M Sc Thesis tanta university tanta 1989139

Elndashsheikh MA Ruderal plant communities of the nile delta region Ph D Thesis Ttanta

university Tanta 1996

Engin E and Treit D The anxiolytic-like effects of allopregnanolone vary as a function of

intracerebral microinfusion site the amygdala medial prefrontal cortex or

hippocampusBehavPharmacol 2007a 18(5-6) 461-470

Engin E Treit D The role of hippocampus in anxiety intracerebral infusion studies

BehavPharmacol 2007b 18 (5-6) 365-374

Ernst E The risk-benefit profile of commonly used herbal therapies ginkgo St Johns

wort ginseng echinacea saw palmetto and kava Ann Intern Med 2002 136 42

Etkin A Functional neuroanatomy of anxiety a neural circuit perspective Curr Top

Behav Neurosci 2010 2 251-277

Evans WC In Trease and Evanrsquos Pharmacognosy 14th

edition Evans W C and Evans

D (eds) WB Saunders London UK 1997 576-578

Farnsworth NR Akerele O Bingel AS Soejarto DD Guo Z Medicinal plants in Therapy

Bulletin of World Health Organ 1985 63 965

Feher M and Schmidt JM Property distributions differences between drugs natural

products and molecules from combinatorial chemistry J Chem Infor Comp Sci 2003 43

218-227

References

164

Fernandez-Gines JM Fernandez-Lopez J Sayas-Barbera E Sendra E Alvarez P Effect of

storage conditions on quality characteristics of bologna sausages made with Citrus Fibre

Journal of Food Science 2003 68(2) 710-715

File SE Factors controlling measures of anxiety and responses to novelty in the mouse

Behav Brain Res 2001 125 151ndash157

Flausino OA Zangrossi H Salgado JV Viana MB Effects of acute and chronic treatment

with Hypericum perforatum L (LI 160) on different anxietyrelated responses in rats

Pharmacology Biochemistry amp Behavior 2002 71 251-257

Frantz S Smith A New drug approvals for 2002 Nat Rev Drug Dis 2003 2 95-96

Frantz S Approvals the demise of the blockbuster Nat Rev Drug Dis 2005 493-94

Fukuchi Y Hiramitsu M Miki O HayashiS Yuka N Toshihiko O Michitaka N Lemon

polyphenols suppress Diet-induced Obesity by Up-Regulation of mRNA Levels of the

Enzymes Involved in β-Oxidation in Mouse White Adipose TissueJ Clin Biochem Nutr

2008 43 201ndash209

Fuster MD In Citrus flavonoids Distribution modulation by phytoregulators and their

possible physiological function PhD Thesis University of Murcia Spain Through Food

Chemistry 2004 84 457-461

Gabor M Szent-Gyorgyi and the bioflavonoids New results and perspectives of

pharmacological research into benzo-pyrone derivatives In Cody V Middleton EJr

Harborne JB Beretz A (eds) Plant Flavonoids in Biology and Medicine II Biochemical

Cellular and Medical Properties Progress in Clinical and Biological Research 280 Alan

R Liss New York 1988

Galati EM Monforte MT Kirjavainen S Forestieri AM Trovato A Tripodo MM

References

165

Biological effects of hesperidin a Citrus flavonoid (note I) Anti inflammatory and

analgesic activity Farmaco 1994 40 709-712

Ganong WF and Lorenzen LC In Neuroendocrinology Vol II Martini L and Ganog WF

(eds) Academic Press New York 1967 2 583

Garcia-Gracia P Lopez-Munoz F Rubio G Martin-Agueda B Alamo C Phytotherapy

and psychiatry bibliometric study of the scientific literature from the last 20 years


Garrett KM Basmadjian G Khan IA Schaneberg BT Seale TW Extracts of kava (Piper

methysticum) induce acute anxiolytic-like behavioral changes in mice

Psychopharmacology (Berl) 2003 170 33-41

Gelder Michael Richard Mayou John Geddes PsychiatryOxford University Press USA

2005

Ghosh MN Fundamentals of Experimental Pharmacology Scientific Book Agency

Calcutta India 1984 156-157

Gilman EF Watson DG Dalbergia sissoo Indian Rosewood Fact sheetST-227

Environmental Horticulture Department Florida Cooperative Extension Service Institute

of Food and Agricultural Sciences Univeristy of Florida USA 1993

Gleeson S Ahlers ST Mansbach RS Behavioral studies with anxiolytic drugs Effects on

punished responding of drugs interacting with serotonin receptor subtypes J Pharmacol

Exp Ther 1989 250 809-17

Glowinski J and Iversen LL Regional studies of catecholamines in the rat brain The

disposition of [3H] norepinephrine [3H] dopamine and [3H] dopa in various regions of the

brain Journal of Neurochemistry 1966 13(8) 655ndash669

References

166

Gohl B Tropical feeds Feed information summaries and nutritive values Fao animal

production and Health series 12Fao Rome Italy 1981 665

Gorinstein S Martin Belloso O Park Y Haruenkit R Lojek A Ciz M Caspi A Libman I

Trakhtenberg S Comparison of some biochemical characteristics of different Citrus fruits

Food Chemistry 2001 74 309-315

Gorman JM New molecular targets for antianxiety interventions J Clin Psychiatry 2003

64(3) 28-35

Gribble Gorden W Switzer FL Richard MS A biometic approach to Elaeocarpus

alkaloids Journal of organic chemistry 1988 53(14) 3164-3170

Gross C Hen R The developmental origins of anxiety Nature Reviews Neuroscience

2004 5 545-552

Gupta AD Aggarwal SS Basu DK Anticonvulsant activity of mixed fatty acids of the

Elaeocarpus ganitrus Roxb Indian J of Physiology Pharmacology 1984 28 245-286

Gupta V Bansal P Kumar S Sannd R Rao MM Therapeutic efficacy of phytochemicals

as anti-anxiety-A Review J of Pharmacy Research 2010 3(1) 174-9

Habib UR Shakirullah M Ahmad I Shah SH Sorption studies of nickel ions onto sawdust

of Dalbergiasissoo Journal of the Chinese Chemical Society 2006 53 1045-1052

Hajare SW Chandra S Sharma J Tondon SK Lal J Telanj AJ Anti-Inflammatory

activity of Dalbergia sissoo leaves Fitoterapia 2001 72 131-139

Hall MG Wilks MF Provan WM Eksborg S Lumholtz B Pharmacokinetics and

pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1 3-cyclohexanedione)

and mesotrione inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a

single dose tohealthy male volunteers B J Clin Pharm 2001 52 169-177

References

167

Handley SL McBlane JW An assessment of the elevated X-maze for studying anxiety and

anxiety-modulating drugs J Pharmacol Toxicol Methods 1993 29(3) 129-138

Handley SL Mithani S Effects of alpha-adrenoceptor agonists and antagonists in a maze-

exploration model of fear-motivated behaviour Naunyn Schmiedebergs Arch Pharmacol

1984 327(1) 1-5

Healy D Psychiatric drugs explained section 5 Management of anxiety Elsevier Health

sciences USA 2008 136ndash137

Heinrich M Teoh HL Galanthamine from snowdrop the development of a modern drug

against Alzheimerrsquos disease from local Caucasian knowledge J Ethnopharmaco 2004 92

147-162

Herrera-Arellano A Ferrer EJ Zamilpa A Valdez MM Valencia CEG Tortoriello J

Efficacy and tolerability of a standardized herbal product from Galphimia glauca on

generalized anxiety disorder A randomized double-blind clinical trial controlled with

lorazepam Planta Medica 2007 73 713-717

Hilditch TP Williams PN The Chemical Constitution of Natural Fats 4th

edition

Spottiswoode Ballantyne amp Co Ltd Great Britain 1964

Hoessel R Leclerc S Endicott JA Nobel ME Lawrie A Tunnah P Leost M Damiens E

Marie D Marko D Niederberger E Tang W Eisenbrand G Meijer L Indirubin the active

constituent of a Chinese antileukaemia medicine inhibits cyclin-dependent kinases Nat

Cel Bio 1999 1 60-67

Holmes A Targeted gene mutation approaches to the study of anxiety-like behavior in

mice Neurosci Biobehav Rev 2001 25 261ndash273

Hood MM Tembhurne SV Sakarkar DM Anthelmintic activity of different extracts of

References

168

Dalbergia sissoo Roxb on Indian Adult Earthworms Der Pharma Chemica 2011 3(2)

142-146

Houghton PJ The scientific basis for the reputed activity of valerian Journal of Pharmacy

and Pharmacology 1999 51 505ndash512

Hwang BY Lee JH Koo TH Kim HS Hong YS Ro JS Lee KS Lee JJ Kaurane

diterpenes from Isodon japonicus inhibit nitric oxideand prostaglandin E2 production and

NF-nB activation in LPS-stimulatedmacrophage RAW2647 cells Planta Med 2001 67

406-410

Indian Pharmacopoeia Ministry of Health and Family Welfare Controller of Publication

New Delhi India 1996

Islam MU Elhddad SA Phytochemical investigation and evaluation of analgesic activity

of ethonolic extract of Dalbergia sissoo (Roxb) bark J Nat Prod Plant Resour 2012

2(6) 701-704

Jackson JY Manual of affore station in Nepal Nepal United Kingdom forest research

project department of forest Kathmandu Nepal 1987 199-214

Javed S Javaid A Zaid M Javaid A Nasim F Biocidal activity of Citrus peel essential

oils against some food spoilage bacteriaJournal of Medicinal Plants Research 2011

5(16) 3697-3701

Jean T Bodinier MC Mediators involved in inflammation Effects of Daflon 500 mg on

their release Anigiology 1994 45 554-559

Johns SR Lamberton JA Sioumis AA Suares H Willing RI Elaeocarpus alkaloids The

alkaloida of Elaeocarpus sphaericus Australian J of chemistry 1971 24(8) 1679-1694

Johns SR Lamberton JA Sioumis AA Suares H Willing RI The structures and absolute

References

169

configuration of seven alkaloids from Elaeocarpus sphaericus Journal of chemical society

D 1970 804-805

Jones FA Herbs--useful plants Their role in history and today Eur J Gastroenterol

Hepatol 1996 8(12) 1227-1231

Jones N King SM Influence of circadian phase and test illumination on pre-clinical

models of anxiety Physiol Behav 2001 72 99ndash106

Kalaskar MG Divekar VB Chaugule PD Surana SJ Baheti DG Studies on anti-diarrheal

activity of Dalberjia sissoo Roxb in experimental animals Pharmacologyonline 2010 1

453-457

Kaplan HI Sadock BJ Comprehensive Textbook of Psychiatry 8th

edition New York

Lippincot Williams and Wilkins 2005

Kapp BW Supple W Pascoe J Amygdaloid contribution to conditioned arousal and

sensory information processing In Aggleton J (ed) The amygdala Neurobiological

aspects of emotion memory and mental dysfunction Weily-Liss New York 1992 29-

254

Karimi E and Jaafar HZE HPLC and GC-MS determination of bioactive compounds in

microwave obtained extracts of three varieties of Labisia pumila Benth Molecules 2011

16 6791-6805

Kashman Y Gustafson KR Fuller RW Cardellina JH McMahon JB Currens MJ

Buckheit RW Hughes SH Cragg GM Boyd MR The calanolides a novel HIV-inhibitory

class of coumarin derivativesfrom the tropical rainforest tree Calophyllum lanigerum J

Med Chem 1992 35 2735-2743

Kaufman PB Cseke LJ Warber S Duke JA Brielmann HL Natural Products from Plants

References

170

CRC Press Boca 1999

Kaur A Singh S Chandra P Suri KA Singh MS Isha Evaluation of antioxidant

potential of stem bark extract of Dalbergia sissoo Journal of Pharmacy Research 2011

4(10) 3439-3441

Kawaii S TomonoY Katase E Ogawa K Yano M Koizumi M Chihiro I Furukawa H

Quantitative study of Flavonoids in leaves of Citrus plants Journal of Agriculture and


Kayastha BP Silvics of the trees of Nepal Community forest development project

Kathmandu 1985

Keay RW Trees of Nigeria Claredon press oxford United kingdom 1989 476

Kessing LV Willer IS Knorr U Volume of the adrenal and pituitary glands in depression

Psychoneuroendocrinology 2011 36 19-27

Kessler RC Berglund P Demler O Jin R Merikangas KR amp Walters EE Lifetime

prevalence and age-of-onset distributions of DSM-IV disorders in the National

Comorbidity Survey Replication Archives of General Psychiatry 2005 62 593-602

Khan ML Putul B Tripathi RS Conservation status of Rudraksha in tropical wet

evergreen forests of Arunachal Pradesh Current Science 2004 86 (5) 646-651

Khan Y Khan RA Afroz S Siddiq A Evaluation of hypolipidemic effect of citrus lemon

Journal of Basic and Applied Sciences 2010 6(1) 39-43

Khanum F and Razack S Anxiety- Herbal Treatment A Review Research and Reviews in

Biomedicine and Biotechnology 2010 1(2) 71-89

Khare CP Encyclopedia of medicinal plants Spring publication New York 2004 198

Khedgikar V Gautam J Kushwaha P Kumar A Nagar GK Dixit P Chillara R Voruganti

References

171

S Singh SP Uddin W Jain GK Singh D Maurya R Chattopadhyay N Trivedi R A

standardized phytopreparation from an Indian medicinal plant (Dalbergiasissoo) has

antiresorptive and bone-forming effects on a postmenopausal osteoporosis model of rat

Menopause 2012 19(12) 1336-46

Kikuchi A Tanida M Uemoyama S Abe T Yamaguchi H Effect of odors on cardiac

response patterns in a reaction time task Chemical Senses 1991 16 183

Kim J Jayaprakasha GK Patil BS Limonoids and their anti-proliferative and anti-

aromatase properties in human breast cancer cells Food Function 2013 4(2)258-65

Kinghorn AD Pharmacognosy in the 21st century J Pharm Pharmacol 2001 53135-148

Kinrys G Coleman E Rothstein E Natural remedies for anxiety disorders potential use

and clinical applications Depression amp Anxiety 2009 26 259-265

Kirtikar KR and Basu BD Indian Medicinal Plants 2nd

edn Lalit Mohan Basu 49-Leader

Road Allahabad India 1933 818

Kirtikar KR Basu BD In Indian Medicinal Plants 2nd

edition Basu LM (ed) I

Allahabad India 1993 488

KirtikarKR Basu BD Indian Medicinal Plants 2nd

edition Jayyed press New Delhi

1975

Knasko SC Ambient odourrsquos effect on creativity mood and perceived health Chemical

Senses 1992 17 27-35

Koehn FE and Carter GT The evolving role of natural products in drug discovery Nat

Rev Drug Dis 2005 4 206-220

Kokate CK Purohit AP Gokhale SB In Pharmacognosy 24th

edition Nirali Prakashan

New Delhi 2003

References

172

Komiya M Takeuchi T Harada E Lemon oil vapor causes an antistress effect via

modulating the 5-HT and DA activities in mice Behavioural Brain Research 2006 172

240-249

Komori T Fujiwara R Tanida M Nomura J Potential antidepressant effects of lemon

odor in rats European Neuropsychophramocology 1995 5 477-480

Koo NH Hong HS Kim CY Ahn JW Lee YG Kim JJ Lyu YS Kim HM Inhibitory

effect of apoptosis in human astrocytes CCf-STTG1 cells by lemon oil Pharmacological

Research 2002 45 469-473

Koyuncu H Berkarda X Baykut F Soybir G Alatli C Gul H Altum M Preventive effect

of hesperidin against inflammation in CD-1 mouse skin caused by tumour promoter

Anticancer Research 199919 3237-3242

Kramer R Cohen D Functional genomics to new drug targets NatRevDrugDis 2004 3

965-972

Krishnamurty HG Sarma KG Seshadri TR Dalbergenone from the heartwood of

Dalbergiasissoo Current science 1963 454-455

Kritikar KR Basu BD Indian medicinal plants 2nd

edition Jayyed press NewDelhi 1975

Kulkarni SK and Reddy DS Animal Behaviour Models for Testing Anti-anxiety Agents

Methods and Findings in Experimental and Clinical Pharmacology 1996 18 219-240

Kulkarni TR Mateenuddin M Bodhankar SL Saharabudhe RA Reversible Anti- Fertility

Effect of Lemon Seeds (Citrus limon) in Male Albino Rats International Journal of

Research in Pharmaceutical and Biomedical Sciences 2012 3 (2) 545-550

Kumar A Hule K Shah AS Manoj N GambhireJuvekar AR An evaluation of the

antidiabetic effects of Elaeocarpus ganitrus in experimental animals Indian J

References

173

Pharmacol 2011 43(1) 56ndash59

Kumar A Narayani M Subanthini A Jayakumar M Antimicrobial Activity and

Phytochemical Analysis of Citrus Fruit Peels -Utilization of Fruit Waste International

Journal of Engineering Science and Technology 2011 3(6) 5414-421

Kumar G Karthik L Rao KVB Antimicrobial activity of Elaeocarpus ganitrus Roxb

(Elaeocarpaceae) An in vitro study Elixir Bio Tech 2011 40 5384-5387

Kumar S Sharma A Anti-anxiety activity studies of various extracts of Turnera

aphrodisiaca Ward Journal of Herbal Pharmacotherapy 2005 5 13-15

Kumar T Shanmugam S Palvannan T KumarVMB Evaluation of antioxidant properties

of Elaeocarpus ganitrus Roxb Leaves Iranian J of pharmaceutical research 2008 7(3)

211-215

Kumari A and Kakkar P Screening of antioxidant potential of selected barks of Indian

medicinal plants by multiple in vitro assays Biomed Environ Sci 2008 21(1) 24-9

Lader M Neurotransmitters and anxiety overview Psychopathology 1984 17(3) 3-7

LakshmiT RoyA Durgha K Manjusha V Coping With Hypertension Using Safer Herbal

Medicine ndash A Therapeutic Review International Journal of Drug Development amp

Research 2011 3(3) 31-57

Landgraf R Neuropeptides and Anxiety Related Behavior Endocrine Journal 2001 48(5)

517-33

Landgraf R Neuropeptides in anxiety modulation Handb Exp Pharmacol 2005 169 335-

69

Langosch JM Zhou XY Heinen M Kupferschmid S Chatterjee SS Noldner M Walden

J St Johns wort (Hypericum perforatum) modulates evoked potentials in guinea pig

References

174

hippocampal slices via AMPA and GABA receptors European

Neuropsychopharmacology 2002 12 209-216

Lario Y Sendra E Perez JG Fuentes C Barbera ES Lopez JF Alvarez JAP Preparation

of high dietary fiber powder from lemon juice by products Innovative Food Science and

Emerging Technologies 2004 5 113-117

Lasisi AA Ejelonu BC Nwosu FO Olayiwola MA Yusuff AHeavy metals and macro-

-nutrients contents in selected herbal plants of south-western Nigeria Hamdard Medicus

2006 4 71-76

Lau WS Infrared characterization for microelectronics World Scientific 1999

LeDoux J Fear and the brain where have we been and where are we going Biol

Psychiatry 1998 44 1229-1238

Lee JH Koo TH Hwang BY Lee JJ Kaurane D Kamebakaurin Inhibits NF-kappa B by

directly targeting the DNA-binding activity of p50 and blocks the expression of

antiapoptotic NF-kappa B target genes J Bio Chem 2002 277 18411-18420

Leon A Portera L Weissman M The Social Costs of Anxiety Disorders Br J Psychiatry

1997 170 205-08

Li Y Sun X LaMont JT Pardee AB Li CJ Selective killing ofcancer cells by beta-

lapachone direct checkpoint activation as a strategyagainst cancer Proceedings of the

National Academy of Sciences of the United States of America 2003 100 2674-2678

Limyati DA Juniar BLL Gendong J A kind of traditional medicine in Indonesia the

microbial contamination of its raw materials and end product Journal of

Ethnopharmacology 1998 63 201-208

Linde K St Johns wort - an overview Forsch Komplementmed 2009 16(3) 146-155

References

175

Lindequist U Niedermeyer TH Julich WD The pharmacological potential of mushrooms

Evid Based Complement Alternat Med 2005 2(3) 285ndash299

Lister RG Ethologically-based animal models of anxiety disorders Pharmacology and

Therapeutics 1990 46 321ndash340

Lister RG The use of the plus-maze to measure anxiety in the mouse

Psychopharmacology 1987 92180ndash185

Loncampt MB Guardiola N Sicot M Bertrand L Perdrix A Duhault J Protective effect

of a purified flavonoids fraction against reactive oxygen radicals Drug Research 1989 39

882-885

Lopes AP Da CI Steffens SM Ferraz A Vargas JC De Lima TC Neto JM Faria MS

Paschoalini MA GABAA and GABAB agonist microinjections into medial accumbens

shell increase feeding and induce anxiolysis in an animal model of anxiety Behav Brain

Res 2007 184 142-149

Lopes LM Goncalves SC Almeida AAD Costa JPD Marques TH Feitosa CM Saldanha

GB Freitas RMD Sedative anxiolytic and antidepressant activities of Citrus limon (Burn)

essential oil in mice Die Pharmazie 2011 66(8) 623-627

Lota LM Serra DDR Tomi F Jacquemond C Casanova J Volatile components of peel

and leaf oils of lemon and lime species Journal of Agriculture and Food Chemistry 2002

50 796-805

Lotsch J and Geisslinger G Morphine-6-glucuronide an analgesic of the future Clin

Pharmacokinetics 2001 40485-499

Lowe IP Robins E Eyerman GS The fluorimetric measurement of glutamic

decarboxylase and its distribution in brain J Neurochem 1958 3 8ndash16

References

176

Lowry JB and Seebeck J The potential for tropical agro forestry in wood and animal feed

production Rural industries research and development corporation publication no 9773

1997

Luypaert J Zhang MH Massart DL Feasibility study for the use of near infrared

spectroscopy in the qualitative and quantitative analysis of green tea Camellia sinensis

(L) Analytica Chimica Acta 2003 478(2) 303-312

Lydiard RB Brawman-Mintzer O Ballenger JC Recent developments in the

psychopharmacology of anxiety disorders JConsult ClinPsychol 1996 64 660-668

Madaan V Wilson DR Neuropeptides relevance in treatment of depression and anxiety

disorders Drug News Perspect 2009 22(6) 319-24

Mallinath H Hugar Kallappa M Hosamani Liyakath-Ahmed MD Phytochemical and

pharmacological studies of ethanol extract of Dalbergia sissoo seeds An approach for the

in-vivo analgesic and antipyretic activities International Journal of Pharma and Bio

Sciences 2010 1(4) 117-123

Mann J Murder Magic and Medicine Oxford University Press Oxford UK 1992 111

Mansur RM Martz W Carlini EA Effects of acute and chronic administration of

Cannabis satisand (-)9-trans tetra hydro cannabinaol on the behaviour of rats in open field

arena Psychopharmacol1980 2 5-7

Marder M Paladini AC GABA-Areceptor ligands of flavonoid structure Current Topics

in Medicinal Chemistry 2002 2(8) 853ndash867

Martinez-Mota L Estrada-Camarena E Lopez-Rubalcava C Indorenate produces

antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors


References

177

Maruti J Dhanavade CB Jalkute JS Ghosh Kailash D Sonawane B Antimicrobial

Activity of Lemon (Citrus lemon L) Peel Extract Journal of Pharmacology and

Toxicology 2011 2(3) 119-122

Mbuya P Msanga HP Ruffo CK Birnie A Tengnaumls B Useful trees and shrubs for

Tanzania identification propagation and management for agricultural and pastoral

communities Regional soil conservation unit (RSCU) Swedish International Development

Authority (SIDA) 1994 6 510-511

McKinney WT Bunney Jr Wed Jr Animal model of depression I Review of evidence

implications for research Arch Gen Psychiatry 1969 21(2) 240-248

Merali Z Bedard T Andrews N Davis B McKnight AT Gonzalez MI Pritchard M Kent

P Anisman H Bombesin receptors as a novel anti-anxiety therapeutic target BB1

receptor actions on anxiety through alterations of serotonin activity J Neurosci 2006a

26(41) 10387-10396

Merali Z Kent P Du L Hrdina P Palkovits M Faludi G Poulter MO Bedard T Anisman

H Corticotropin-releasing hormone arginine vasopressin gastrin-releasing peptide and

neuromedin B alterations in stress-relevant brain regions of suicides and control subjects

BiolPsychiatry 2006b 59(7) 594-602

Merikangas RK Pine D Genetic and other vulnerability factors for anxiety and stress

disorders In Davis KL Charney D Coyle JT Nemeroff C (Eds)

Neuropsychopharmacology The fifth generation of progress Philedelphia Lipincott-

William amp Wilkins USA 2002 868-82

Ministry of health amp family welfare The Ayurvedic Pharmacopoeia of India Partndash I

Volume ndash III Department of Indian systems of medicine amp homeopathy Govt of

References

178

India New Delhi 2001

Misar AV Kale M Joshi M Mujbumder AM Analgesic activity of Dalbergia lanceolaria

bark extract in swiss albino mice Pharm Biol 2005 43 723-725

Mitchell G Bartlett DW Fraser TE Hawker TR Holt DC Townson JK Mosetrione a

new selective herbicide for use in maize Pest Management Science 2001 57 120-128

Miyake Y Yamamoto K Morimitsu Y Osawa T Isolation of C-glucosylflavone from

lemon peel and antioxidative activity of flavonoid compounds in lemon fruit Journal of

Agricultural and Food Chemistry 1997 45 4619-4623

MiyakeY Yamamoto K Morimitsu Y Osawa T Characterization of antioxidative

flavonoids glycosides in lemon fruit Food Science Technology International Tokyo1998

4 48-53

Mohammadian MA Zahra KL Reza HS Quantitative and qualitative comparison of

antioxidant activity in the flavedo tissue of three cultivars of citrus fruit under cold stress

Australian Journal of Crop Science 2012 6(3) 402-406

Monajemia A Shahrbanoo O Ali HR Ghannadid A Jafarian A Cytotoxic Effects of

Essential Oils of Some Iranian Citrus Peels Iranian Journal of Pharmaceutical Research

2005 3 183-187

Monforte MT Trovato A Kirjarainen S Forestieri AM Galati EM Locurto RB

Biological effects of hesperidin a Citrus flavonoid (Note II) Hypolipidemic activity on

experimental hypercholesterolemia in rat Farmaco 1995 9 595-599

Montgomery KC The relation between fear induced by novel stimulation and exploratory

behavior Journal of Comparative Physiology and Psychology 1955 48 254-260

Movafegh A Alizadeh R Hajimohamadi F Esfehani F and Nejatfar M Preoperative

References

179

oral Passiflora incarnata reduces anxiety in ambulatory surgery patients a doubleblind

placebo-controlled study Anesthesia amp Analgesia 2008 106 1728-1732

Mujumdar AM Misar AV Upadhye AS Antidiarrhoel activity of ethanol extract of the

bark of Dalbergia lanceolaria J Ethnopharmacol 2005 102 213-216

Mukerjee SK Saroja T Seshadri TR Dalbergichromene A new neoflavonoid from stem-

bark and heartwood of Dalbergia sissoo Tetrahedron 1971 27(4) 799-803

Muller D Pfeil T Von DV Treating depression comorbid with anxiety-results of an open

practice-oriented study with St Johns wort WS 5572 and valerian extract in high doses


Mundy C Kirkpatrick P Tiotropium bromide Nat Rev Drug Dis 2004 3 643

Munne S Dilip P Vishwas I Vijay N Evaluation of the anthelmintic activity of Citrus

limon juice sacs International Journal of Pharma Professionalrsquos Research 2011 2(2)

278-280

Muthiah PL In vitro xanthine oxidase inhibitory activity of leaves fruits and peel extracts

of Citrus aurantium Citrus limetta and Citrus limon International Journal of

Phytopharmacy 2012 2(3) 77-82

Nadkarni AK Indian Material Medica Popular Prakashan Bombay 1982 1 432

Nadkarni KM Indian Material Medica 3rd edition Bombay Popular Book Depot 1954 1

432

Naganuma M Hirose S Nakayama Y Nakajima K Someya T A study of the

phototoxicity of lemon oil Archieves of Dermatological Research 1985 278(1) 31-36

Nath Gopal Singh RK Antimicrobial activity of Elaeocarpus sphaericus Phytotherapy

research 1999 13(5) 448-450

References

180

National Institute of Mental Health (NIMH) The numbers count Mental disorders in

America 2012 Retrieved fromhttpwwwnimhnihgovhealthpublicationsthe-numbers-

countmental-disorders-in-americaindexshtml assessed on January 2013

Nestoros JN GABAergic mechanisms and anxiety an overview and a new

neurophysiological model Can J psychiatry 1984 29(6) 520-9

Newman DJ Cragg GM Snader KM Natural products as sources of new drugs over the

period 1981-2002 J Nat Prod 2003 66 1022-1037

Newman DJ Cragg GM Snader KM The influence of natural products upon drug

discovery Nat Prod Rep 2000 17 215-234

Nicolaou KC Snyder SA The essence of total synthesis Proceedings of the National

Academy of Sciences of the United States of America 2004 101 11929-11936

Ninan PT The Functional Anatomy Neurochemistry and Pharmacology of

Anxiety Journal of Clinical Psychiatry 1999 60(22) 12-17

Obi E Akunyili DN Ekpo B Orisakwe OE Heavy metal hazards of Nigerian herbal

remedies Sci Total Environ 2006 369 (1-3) 35-41

Okerulu IO Ani CJ The Phytochemical Analysis and Antibacterial screening of Extracts

of Tetracarpidium Conophorum J Chem Soc Nig 2001 26 1

Okouneva T Hill BT Wilson L Jordan MA The effects of vinflunine vinorelbine and

vinblastine on centromere dynamics Mol Can Therapy 2003 2 427-436

Oshaghi1 MA Ghalandari R Vatandoost H Shayeghi 1M Kamali NM Tourabi KH

Abolhassani M Hashemzadeh M Repellent Effect of Extracts and Essential Oils of Citrus

limon(Rutaceae) and Melissa officinalis (Labiatae) Against Main Malaria Vector

Anopheles stephensi (Diptera Culicidae) Iranian J Publ Health 2003 32(4) 47-52

References

181

Ososki AL Lohr P Reiff M Balick MJ Kronenberg F Beran AF Oconnor B

Ethnobotanical literature survey of medicinal plants in the Dominican Republic used for

womenrsquos health conditions Journal of Ethnopharmacology 2002 79 285-298

Otero R Nunez V Jimenez SL Osorio RG Garica ME Diaz A Snakebites and

ethnobotany in northwest region of Colombia Part II Neuralization of lethal and

enzymatic effects of Bothraps atrox Venom Journal of Ethnopharmacology 2000a71

505-511

Otero R Nunez V Barona J Fonnegia R Jimenez SL Osorio RG Saldarriage M Diaz A

Snakebites and ethnobotany in the northwest region of Colombia Part III Neutralization

of the haemorrhagic effect of Bothrops atrox venom Journal of Ethnopharmacology

2000b 73 233-245

Paladini AC Marder M Viola H Wolfman C Wasowaki C Medina JH Flavonoids and

the central nervous system from forgotten factors to potent anxiolytic compounds J

Pharm Pharmacol 1999 51 519-526

Panday VB and Bhattacharya SK Scientific appraisal of rudraksha (Elaeocarpus ganitrus)

chemical and pharmacological studies J Res Edu Ind Med1985 4 47-50

Pare D Quirk GJ Ledoux JE New vistas on amygdala networks in conditioned fear J

Neurophysiol 2004 92(1) 1-9

Park HJ Kim HY Yoon KH Kim KS Shim I The Effects of Astragalus Membranaceus

on Repeated Restraint Stress-induced Biochemical and Behavioral Responses Korean

Journal of Physiology and Pharmacology 2009 13 315-319

Parkash R and Hocking D Some favorite trees for fuel and fodder Society for promotion

of wastelands development New Delhi India 1986 4 42-49

References

182

Parrotta JA Dalbergia sissoo Roxb Silvics of forest trees of American tropics Dept of

Agriculture Forest services Forest experimental station SO-ITF-SM-24 New Orleans

Los Angeles USA 1989 5

Pellow S Chopin P File S Briley M Validation of open closed arm entries in an elevated

plus-maze as a measure of anxiety in the rat J Neurosci Methods 1985 14 149ndash167

Pellow S File SE Anxiolytic and anxiogenic drug effects on exploratory activity in an

elevated plus-maze a novel test of anxiety in the rat Pharmacology Biochemistry and

Behavior 1986 24 525ndash529

Perez RM Perez JA Garcia LM Sossa H Neuropharmacological activity of Solanum

nigrum fruit J Ethnopharmacol 1998 62 43-48

Pesold C and Treit D The central and basolateral amygdala differentially mediate the

anxiolytic effects of benzodiazepines Brain Res 1995 671(2) 213-221

Peterson EA and Overman LE Contiguous stereogenic quaternary carbons adaunting

challenge in natural products synthesis Proceedings of the National Academy of Sciences

of the United States of America 2004 10111943-11948

Pezzuto JM Song LL Lee SK Shamon LA Mata-Greenwood E Jang M Jeong HJ Pisha

E Mehta RG Kinghorn AD Bioassay methods useful for activity-guided isolation of

natural product cancer chemopreventive agents In Hostettmann K Gupta MP Marston A

(eds) Chemistry Biological and Pharmacological Properties of Medicinal Plants from the

Americas Harwood Academic Press Amster-dam USA 1999 81-110

Pezzuto JM Plant-derived anticancer agents Biochem Pharmacol 1997 53 121-133

Phil P Standard Definitions of Terms Relating to Mass Spectrometry A report from the

committee on measurements and standards of the American Society for Mass

References

183

Spectrometry Journal of the American Society for Mass Spectrometry 1991 2(4) 336ndash

348

PIER (PACIFIC ISLAND ECOSYSTEMS AT RISK) Dalbergia sissoo 2006

httpwwwhearorgpier speciesDalbergia_sissoohtml

Piggott AM and Karuso P Quality not quantity The role of natural products and chemical

proteomics in modern drug discovery Comb Chem 2004 7 607-630

Pirttila T Wilcock G Truyen L Damaraju CV Long-term efficacy and safety of

galantamine in patients with mild-to-moderate Alzheimerrsquos disease multicenter trial Eur

J Neurology 2004 11 734-741

Pisha E Chai H Lee IS Chagwedera TE Farnsworth NR Cordell GA Beecher CW Fong

HH Kinghorn AD Brown DM Wani MC Wall ME Hieken TJ Das Gupta TK Pezzuto

JM Discovery of betulinic acid as a selective inhibitor of human melanoma that functions

by induction of apoptosis Nat Medicine 1995 11046-1051

Pitchaiah G Viswanatha GL Srinath R Nandakumar K Dayabaran D Florance

EJAnxiolytic and anticonvulsant activity of aqueous extract of stem bark of

Erythrinavariegatain rodents Int J Parm Tech Res 2010 2(1) 40-48

Pooja SharmaP Samanta KC Garg V Evaluation Of Nitric Oxide And Hydrogen

PeroxideScavenging Activity Dalbergia sissoo roots Pharmacophore 2010 1(2) 77-81

Preetha B Judia HSV Antibacterial Activity of Citrus Fruits against Vibrio cholerae

Herbal Tech Industry 2011 14-15

Pullaiah T Citrus Encyclopedia of World Medicinal Plants Regency Publications New

Delhi 2006 2 578

Pund KV Vyawahare NS Gadakh RT Murkute VK Antidiabetic Evaluation of Dalbergia

References

184

sissoo against alloxan induced diabetes mellitus in wistar albino rats J Nat Prod Plant

Resour 2012 2(1) 81-88

Rabbani M Sajjadi SE Mohammadi A Evaluation of the anxiolytic effect of Nepeta in

mice Evid Based Complement Alternat Med 2008 5 181 - 186

Rakotonirina VS Bum EN Rakotonirena A Bopelet M Sedative properties of the

decoction of the rhizome of Cyperus anticulatives Fitoterapia 2001 72 22 - 29

Ramadurai L The Rudraksha Tree Conservation of Ecological Heritage and Sacred Sites

of India 2007-2008 6 (2)

Ramireddy O-Prenylated flavonoids from Dalbergia sissoo Phytochemistry 2008 11 (1)

23-26

Rana V Kumar V Soni PL Structure of the oligosaccharides isolated from Dalbergia

sissoo Roxb leaf polysaccharide Carbohydrate Polymers 2009 78(3) 520-525

Rana V Kumar V International Journal of Chem Tech Research 2011 3(1) 483-487

Rao SK Rao OU Aminabee SK Rao RM Rao AL Hypoglycemic and antidiabetic

potential of chitosan aqueous extract of Elaeocarpus ganitrus International Journal of

Research in Pharmacy and Chemistry 2012 2(2) 428-41

Rastogi R and Mehrotra BN Compendium of Indian Medicinal plants Vol 1 Central

Drug Research Institute Lucknow and National Institute of Science Communication New

Delhi India1990

Rauniar GP Deo S Bhattacharya SK (1990) Evaluation of anxiolytic activity of tensarin

in mice Kathmandu Univ Med J 2007 5(2) 188-94

Ray AB Chand L Pandey VB Rudrakine A new alkaloid from Elaeocarpus ganitrus

Phytochemistry 1979 18 700-701

References

185

Rekha CG Poornima M Manasa V Abhipsa J Pavithra D Vijay K Prashith K

Ascorbic Acid Total Phenol Content and Antioxidant Activity of Fresh Juices of Four

Ripe and Unripe Citrus Fruits Chem Sci Trans 2012 1(2) 303-310

Rodgers RJ and Cole JC Anxiolytic-like effect of (S)-WAY 100135 A 5-HT1A receptor

antagonist in the murine elevated plus-maze test Eur J Pharmacol 1994 261(3) 321-325

Rodgers RJ Cao BJ Dalvia A Holmes A Animal models of anxiety an ethological

perspective Brazilian Journal of Medical and Biological Research 1997 30 289-304

Rodgers RJ and Dalvia A Anxiety defence and the elevated plus-maze Neurosci

Biobehav Rev 1997 21(6) 801-810

Roy N Laskara RA Ska I Kumaria D Ghoshb T Begum NA A detailed study on the

antioxidant activity of the stem bark of Dalbergia sissoo Roxb an Indian medicinal plant

Food Chemistry 2011 126 (3) 1115ndash1121

Roy SD Bania1 R Chakraborty J Goswami R Laila R Ahmed SA Pharmacognostic

phytochemical physicochemical property and antimicrobial activity studies of lemon peel

oil Scholars Research Library J Nat Prod Plant Resour 2012 2(3) 431-435

Ruberto G Renda A Tringali C Napoli EM Simmonda MSJ Citrus limonoids and their

semisynthetic derivatives as antifeedent agents against Spodaptera frugiperda Larvae A

structure activity relationship study Journal of Agricultural and Food Chemistry 2002 50

6766-6774

Saeed SA Bloch RM Antonacci DJ Herbal and dietary supplements for treatment of

anxiety disorders American Family Physician 2007 76 549-556

Sah P Faber ES Lopez De Armentia M Power J The amygdaloid complex anatomy and

physiology Physiol Rev 2003 83 803-834

References

186

Sakat SS Wankhede SS Juvekar AR Mali VR Bodhankar SL Antihypertensive activity

of aqueous extract of Elaeocarpus ganitrus Roxb Seeds in renal artery occluded

hypertensive rats International J of Pharma Tech Research 2009 1 779-782

Salgueiro JB Ardenghi P Dias M Ferreira MB Izquierdo I Medina JH Anxiolytic

natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no

effect on memory tasks in rats Pharmacol Biochem Behav 1997 58 887-891

Salwa F Amany S Ahmed Terashima K Takaya Y Niwa M Isoflavonoid glycosides

from Dalbergia sissoo Phytochemistry 2001 57(8) 1263-1268

Samuelsson G Drug of natural origin A textbook of Pharmacognosy 5th

edition Sweden

Pharmaceutical Press Stockholm 2004

Sarris J Kavanagh DJ Byrne G Bone KM Adams J Deed G The Kava Anxiety

Depression Spectrum Study (KADSS) a randomized placebo-controlled crossover trial

using an aqueous extract of Piper methysticum Psychopharmacology (Berl) 2009 205

399-407

Sarris J and Kavanagh DJ Kava and St Johns Wort current evidence for use in mood and

anxiety disorders JAlternComplement Med 2009 15(8) 827-836

Sasidharan S Y Chen D Saravanan KM Sundram Latha LY Extraction Isolation and

Characterization of Bioactive Compounds from Plants Extracts Afr J Tradit Complement

Altern Med 2011 8(1) 1ndash10

Schmidt B Ribnicky DM PoulevA LogendraS Cefalu WT and Raskin I A natural

history of botanical therapeutics Metabolism 2008 57(7) 3-9

Shah G Shri R Mann A Rahar S Panchal V Anxiolytic effects of Elaeocarpus

sphaericus fruits on the elevated plus-maze model 2010 2(3) 1781-1786

References

187

Sharma A Chibber SC Chawla HM Caviunin 7-O-gentiobioside from Dalbergia sissoo

pods Phytochemistry 1979 18(1) 1253-1253

Sharma MK Singal M Pokhriyal TC Dalbergia sissoo in India Proceedings of the

sub-regional seminar die-back of sissoo (Dalbergia sissoo) Food and agriculture

organization of the United Nations (FAO) FAO corporate document repository 2000

Sharma SC and Roy RK Bioremediation of urban environmental Pollution by

ornamentals Journal of Environment Science Engineering 1999 47 131-134

Shazid MD Sharkar Shahid J Assesment of antibacterial and cytotoxic activity of

some locally used medicinal plants in Sunderban mangrove forest region African J of

pharmacy and pharmacology 2010 4(2) 066-069

Sheehan DV and Sheehan KH Current approaches to the pharmacologic treatment of

anxiety disorders Psychopharmacology bulletin 2007 40 98-109

Sheikh MI NFT highlights sissoo-the versatile rosewood NFTA 89-07 forest farm and

community tree network Winrock international Morrilton USA 1989 72110-9370

Shekhar A Sajdyk TJ Gehlert DR Rainnie DG The amygdala panic disorder and

cardiovascular responses Ann N Y Acad Sci 2003 985 308-325

Shekhar A Truitt W Rainnie D Sajdyk T Role of stress corticotrophin releasing factor

(CRF) and amygdala plasticity in chronic anxiety Stress 2005 8 209-219

Shrestha SP Amano Y Narukawa Y Takeda T Nitric oxide production inhibitory activity

of flavonoids contained in trunk exudates of Dalbergia sissoo J Nat Prod 2008 71(1)

98-101

Shrivastava V Purwal L Jain UK In-vitro pediculicidal activity of juice of Citrus limon

International Journal of Pharm Tech Research 2010 2(3) 1792-1795

References

188

Sidana Jk Saini V and Dahiya S Analgesic and anti-inflammatory activities of Dalbergia

Sissoo leaves extract International Journal of Natural Product Science 2011 2(1) 76ndash79

Sieghart W Sperk G Subunit composition distribution and function of GABA(A)

receptor subtypes Curr Top Med Chem 2002 2(8) 795-816

Singewald N Sinner C Hetzenauer A Sartori SB Murck H Magnesium-deficient diet

alters depression- and anxiety-related behavior in mice-influence of desipramine and

Hypericum perforatum extract Neuropharmacology 2004 47 1189-1197

Singh B Sharma A Ishar MPS Antianxiety investigations of Centaurea behen Linn

and Elaeocarpus ganitrus Roxb Journal of Pharmacy Research 2012 5(3) 1483-1486

Singh RH and Chaturvedi GN Inhibition of formaldehyde induced arthritis by certain

indigenous drugs Indian JMed Res1966 54 188-195

Singh RK Acharya SB Bhattacharya SK Pharmacological activity of Elaeocarpus

sphaericus Phytotherapy research 2000a 14 36-39

Singh RK Bhattacharya SK Acharya SB Studies on extracts of Elaeocarpus sphaericus

fruits on in vitro rat mast cells Phytomedicine 2000b 7(3) 205-207

Skoog DA Holler FJ Crouch SR Principles of Instrumental Analysis 6th

edition

Thomson BrooksCole USA 2007169-173

Solomon FG Amktaut AA and Rubin JR In Stress psychological and physiological

interactions Hemisphere Publishing Corporation Washington USA 1985

Somers JM Goldner EM Waraich P Hsu L Prevalence and incidence studies of anxiety

disorders a systematic review of the literature Canadian Journal of Psychiatry 2006 51

100-113

Sparreboom A Cox MC Acharya MR Figg WD Herbal remedies in the United States

References

189

potential adverse interactions with anticancer agents Journal of Clinical Oncology 2004

22 2489-2503

Spielberger CD Gorsuch RL Lushene RE Manual for the State-Trait Anxiety

Inventory Consulting Psychologists Press Palo Alto California USA 1970

Spinella M Herbal Medicines and Epilepsy The Potential for Benefit and Adverse

Effects Epilepsy Behav 2001 2(6) 524-532

Stevinson C and Ernst E Valerian for insomnia a systematic review of randomized

clinical trials Sleep Medicine 2000 1 91-99

Sticher O Natural product isolation- A review Nat Prod Rep 2008 25 517ndash554

Still WC Kahn M Mitra A Rapid Chromatographic Technique For Preparative

Separations With Moderate Resolution J Org Chem 1978 43 2923-2925

Swami G Nagpal N Rahar S Singh P Singla S Porwal A Kapoor R Elaeocarpus

sphaericus Medical and scientific facts Scholars research library 2010 2(1) 297-306

Swanson LW and Petrovich GD What is the amygdala Trends Neurosci 1998 21 323-

331

Takada Y Urano T Malyszko T and Takada A Changes in serotonergic measures in

whole blood and various brain regions of rats administered with the 5-HT-sub(1A ) agonist

tandospirone andor exposed to electric foot-shock Brain Res Bull 1996 40(1) 51-55

Tallman JF Cassella J Kehne J Mechanism of Action of Anxiolytics In Neuropsycho-

pharmacology The fifth Generation of Progress Philedelphia Lipincott-William amp

Willkins USA 2002 993-1006

Tanaka M Yoshida M Emoto H Ishii H Noradrenaline systems in the hypothalamus

amygdala and locus coeruleus are involved in the provocation of anxiety basic studies

References

190

European Journal of Pharmacology 2000 29 397-406

Tanaka T Makita H Mori H Chemoprotection of 4-Noo-induced oral carcinogenesis by

dietary flavonoids diosmin and hesperidin Recent Advances in Gestroenterological

Carcinogenesis 1996 1 1167-1170

Tewari DN A Monograph on Dalbergia sissoo Roxb International book distributors

Dehra Dun India 1994 202

Thorsell A Carlsson K Ekman R Heilig M Behavioral and endocrine adaptation and up-

regulation of NPY expression in rat amygdala following repeated restraint stress Neuro

report 1999 10(14) 3003-3007

Treit DA Comparison of anxiolytic and non anxiolytic agents in the shock-probeburying

test for anxiolytics Pharmacol Biochem Behav 1990 36(1) 203-205

Treit D Pesold C Rotzinger S Dissociating the anti-fear effects of septal and amygdaloid

lesions using two pharmacologically validated models of rat anxiety Behav Neurosci

1993 107 770-785

Tsuchiya T Tanida M Uenoyama S Nakayama Y Ozawa T Effects of olfactory

stimulation on the sleep time induced by pentobarbital administration in mice Brain

Research Bulletin 1991 26 397-401

Turner RA Screening method in pharmacology Academic Press New York USA 1965

152

Udenfriend S Titus E Weissbach H The identification of 5-hydroxy-3-indoleacetic acid

in normal urine and a method for its assay Journal of Biological Chemistry 1955 215

337-344

Udupa KN Disorders of stress and their management by Yoga A study of neuro-

References

191

humoral response BHU Press Varanasi India 1978

Uhlenhuth EH Balter MB Ban TA Yang K Trends in recommendations for the

pharmacotherapy of anxiety disorders by an international expert panel 1992-1997

Eur Neuropsychopharmacol 1999 9(6) S393-398

Van Agtmael MA Eggelte TA Van Boxtel CJ Artemisinin drugs in the treatment of

malaria from medicinal herb to registered medication Tre Pharmac Sci 1999 20 199-

205

Vankar Padma S Shukla Dhara Biosynthesis of silver nanoparticles using lemon

leaves extract and its application for antimicrobial finish on fabric Applied Nanoscience

2012 2(2) 163-168

Vasudeva N Vats MJ Anti-spermatogenic activity of ethanol extract of Dalbergia sissoo

Roxb stem bark Acupunct Meridian Stud 2011 2 116-122

Vekiari SA Pratopapadakis EE Papadopoulou P Papanicalaou D Panou C Vamvakias

M Composition and seasonal variation of the essential oil from leaves and peel of a Cretan

lemon variety Journal of Agricultural and Food Chemistry 2002 50 147-153

Viuda-Martos M Y Ruiz-Navajas J Fernandez-lopez J Perez-Alvarez Antibacterial

activity of lemon (citrus lemon) mandarin (citrus reticulata) grapefruit (citrus paradisi)

and orange (citrus sinensis) essential oil Journal of Food Safety 2008 28(4) 567ndash576

Vorbach EU Gortelmeyer R Bruning J Therapy of insomnia The efficacy and tolerability

of valerian Psychopharmakotherapie 1996 3 109ndash115

Waidulla N Siba MAA Nahla AH Tawfik O Evaluation of the Antibacterial Activity of

Citrus Juices An In Vitro Study AlndashRafidain Dent J 2010 10(2) 376-382

Walf AA and Frye CA The use of the elevated plus maze as an assay of anxiety-

References

192

related behavior in rodents Nat Protoc 2007 2(2) 322-328

Wambebe C Development of standardized phytomedicines in Africa Journal of

Pharmaceutical Research and Development 1998 3 1-11

Wang Distribution Synthesis and Biological Activity of Dalbergin Natural Product

Research and Development 2009 21(5) 900-904

Ward CP Redd K Williams BM Caler JR Luo Y McCoy JG Ginkgo biloba extract

cognitive enhancer or anti stress buffer Pharmacology Biochemistry amp Behavior 2002 72

913-922

Watkins LL Connor KM Davidson JR Effect of kava extract on vagal cardiac control in

generalized anxiety disorder preliminary findings Journal of Psychopharmacology 2001

15 283-286

Weeks BS Formulations of dietary supplements and herbal extracts for relaxation and

anxiolytic action Relarian TM Med Sci Monit 2009 15 (11) 256-262

Welch AS and Welch BL Solvent extraction method for simultaneous determination of

norepinephrine dopamine serotonin and 5-hydroxyindoleacetic acid in a single mouse

brain Analytical Biochemistry 1969 30 161-179

White KJ Domestication and breeding programme for DalbergiasissooRoxb Undpfao

regional project improved productivity of manmade forest through technological advances

in tree breedingand propagation Ras91004 ecosystem research and development bureau

(erdb) Philippines 1994

William SMass spectroscope for analysis in the low-mass range Review of Scientific

Instruments 1947 18(8) 540ndash545

Wink M Introduction biochemistry role and biotechnology of secondary products

References

193

In M wink (ed) Biochemistry of Secondary Product Metabolism CRC Press Boca Raton

FL 1999 1-16

Woelk H Arnoldt KH Kieser M Hoerr R Ginkgo biloba special extract EGb 761

in generalized anxiety disorder and adjustment disorder with anxious mood a randomized

double-blind placebo-controlled trial Journal of Psychiatric Research 2007 41 472-480

Wolfman C Viola H Paladini A Dajas F Medina E Possible anxiolytic effects of

chrysin a central benzodiazepine receptor ligand Isolated from Passiflora coerulea

Pharmacology Biochemistry and Behavior 1994 47(1) 1-4

Wonnemann M Singer A Muller WE Inhibition of synaptosomal uptake of 3H-

Lglutamate and 3H-GABA by hyperforin a major constituent of St Johns Wort the role

of amiloride sensitive sodium conductive pathways Neuropsychopharmacology 2000 23

188-197

World Health Organization Composite International Diagnostic Interview (CIDI) 21

Geneva Switzerland WHO 2001

World Health Report 2004 Changing History Annex Table 3 Burden of disease in

DALYs by cause sex and mortality stratum in WHO regions estimates for 2002

Retrieved from httpwwwwhoint whr2004enreport04_enpdf

Wunderlin RP Hansen BF Atlas of Florida vascular plants University of South Florida

Tampa USA 2002 (wwwworldagroforestrycentreorg)

Yadav H Yadav M Jain S Bhardwaj A Singh V Parkash O Marotta F Antimicrobial

property of a herbal preparation containing Dalbergia sissoo and Datura tramonium with

cow urine against pathogenic bacteria Int J Immunopathol Pharmacol 2008 21(4) 1013-

1020

References

194

Yan HC Hong P Zhang ZY Song J Evaluation of antioxidant and antitumour activities

of lemon essential oil Journal of Medicinal Plants Research 2010 4(18) 1910-1915

Yang SS Cragg GM Newman DJ Bader JP Natural product-based anti-HIV drug

discovery and development facilitated by the NCI developmental therapeutics program J

Nat Prod 2001 64 265-277

Young R Johnson DN A fully automated lightdark apparatus useful for comparing

anxiolytic agents Pharmacol Biochem Behav1991 40 739ndash743

Yu D Suzuki M Xie L Morris NSL Lee KH Recent progressin the development

of coumarin derivatives as potent anti-HIV agents Med Res Rev 2003 23 322-345

Zabala NQ Plantation Silviculture FAO of the UNO part of projects BGD85011 Field

Document No 19 Rome Italy 1990 236

Zayed AA Rokaya MA Saeed Amira H Hanam M Heba Y Mady I Influence of allium

sativum and Citrus limon oil extracts and Bacillus thuringiensis israelensis on some

biological aspects of Culex pipiens larvae World Journal of Zoology 2009 4(2) 109-121

Ziegler G Ploch M Miettinen-Baumann A Collet W Efficacy and tolerability of valerian

extract LI 156 compared with oxazepamin the treatment of non-organic insomnia a

randomized double blind comparative clinical study European Journal of Medical

Research 2002 7 480ndash486

References

195

wwwrudraksha-ratnacom


wwwrudrakshanepalcom

wwwayushvedacomherbs Elaeocarpus ganitrushtm


wwwhandicraft-Indiamartcom

httprudrakshamht2009

httpenwikipediaorgwikilemon

References

152

prefrontal cortex and amygdala BehavBrain Res 2009 203(2) 279-287

Aloisi AM Ceccarelli I Masi F Scaramuzzino A Effects of the essential oil from Citrus

limon in male and female rats exposed to a persistent painful stimulation Behavioural

Brain Research 2002 136 127-135

Alonso J and Lepine JP Overview of key data from the European Study of the

Epidemiology of Mental Disorders Journal of Clinical Psychiatry 2007 68 3-9

Amolkar HK Archana JR Effect of alkaloidal fraction of Elaeocarpus ganitrus seeds on

murine in vitroimmune parameters Journal of Pharmacy Research 2009 2(7) 1261-1265

Amsterdam JD Li Y Soeller I Rockwell K Mao JJ Shults J A randomized doubleblind

placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for

generalized anxiety disorder Journal of Clinical Psychopharmacology 2009 29 378-382



Communication New Delhi India 1950 3



Communication New Delhi India 1992 3 609-678

Anonymous The Wealth of India A dictionary of Indian raw materials and industrial

product first supplement series D-I (Raw Materials) National Institute of Science

Communication New Delhi India 2001 3 58

Ansari MA Razdan RK Tandon M Vasudeva P Larvicidal and reppellant actions of

Dalbergis sisso Roxb (Family Leguminasae) oil against mosquitoes Bioresource Tech

2010 73(3) 207-211

References

153





95





2(1) 76-79



India 1992 289








3(1) 1913-1919



References

154







78 431-441




506




1073-1093




1993 112(1) 1-12





References

155

133-140






99






1998






Rev 1998 3(4) 271-280





References

156
















Pharmacology 2003 463(1-3) 55-65


3) 55-65






References

157


38(2) 120-124




1330



303






2141-2153




1996 53 2349-2353




Research 1999 25 281-287

References

158


J Mol Graph Model 2007 25(5) 721-730




2311








Behavior 2003 75 501-512



1205







References

159

1963 52 907-909




Delhi 1993 90-91



Med Res Rev 2004 24 90-114





Psychiatry 2009 22(1) 90-95





777ndash785






References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

153





95





2(1) 76-79



India 1992 289








3(1) 1913-1919



References

154







78 431-441




506




1073-1093




1993 112(1) 1-12





References

155

133-140






99






1998






Rev 1998 3(4) 271-280





References

156
















Pharmacology 2003 463(1-3) 55-65


3) 55-65






References

157


38(2) 120-124




1330



303






2141-2153




1996 53 2349-2353




Research 1999 25 281-287

References

158


J Mol Graph Model 2007 25(5) 721-730




2311








Behavior 2003 75 501-512



1205







References

159

1963 52 907-909




Delhi 1993 90-91



Med Res Rev 2004 24 90-114





Psychiatry 2009 22(1) 90-95





777ndash785






References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

154







78 431-441




506




1073-1093




1993 112(1) 1-12





References

155

133-140






99






1998






Rev 1998 3(4) 271-280





References

156
















Pharmacology 2003 463(1-3) 55-65


3) 55-65






References

157


38(2) 120-124




1330



303






2141-2153




1996 53 2349-2353




Research 1999 25 281-287

References

158


J Mol Graph Model 2007 25(5) 721-730




2311








Behavior 2003 75 501-512



1205







References

159

1963 52 907-909




Delhi 1993 90-91



Med Res Rev 2004 24 90-114





Psychiatry 2009 22(1) 90-95





777ndash785






References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

155

133-140






99






1998






Rev 1998 3(4) 271-280





References

156
















Pharmacology 2003 463(1-3) 55-65


3) 55-65






References

157


38(2) 120-124




1330



303






2141-2153




1996 53 2349-2353




Research 1999 25 281-287

References

158


J Mol Graph Model 2007 25(5) 721-730




2311








Behavior 2003 75 501-512



1205







References

159

1963 52 907-909




Delhi 1993 90-91



Med Res Rev 2004 24 90-114





Psychiatry 2009 22(1) 90-95





777ndash785






References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

156
















Pharmacology 2003 463(1-3) 55-65


3) 55-65






References

157


38(2) 120-124




1330



303






2141-2153




1996 53 2349-2353




Research 1999 25 281-287

References

158


J Mol Graph Model 2007 25(5) 721-730




2311








Behavior 2003 75 501-512



1205







References

159

1963 52 907-909




Delhi 1993 90-91



Med Res Rev 2004 24 90-114





Psychiatry 2009 22(1) 90-95





777ndash785






References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

157


38(2) 120-124




1330



303






2141-2153




1996 53 2349-2353




Research 1999 25 281-287

References

158


J Mol Graph Model 2007 25(5) 721-730




2311








Behavior 2003 75 501-512



1205







References

159

1963 52 907-909




Delhi 1993 90-91



Med Res Rev 2004 24 90-114





Psychiatry 2009 22(1) 90-95





777ndash785






References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

158


J Mol Graph Model 2007 25(5) 721-730




2311








Behavior 2003 75 501-512



1205







References

159

1963 52 907-909




Delhi 1993 90-91



Med Res Rev 2004 24 90-114





Psychiatry 2009 22(1) 90-95





777ndash785






References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

159

1963 52 907-909




Delhi 1993 90-91



Med Res Rev 2004 24 90-114





Psychiatry 2009 22(1) 90-95





777ndash785






References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

160



270 (6) 82-87













1386






645-651


References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

161



Drug Research 1987 37 1149-1153


613-34


1992 15 353-375

















References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

162



Med Chem Lett 2012 22(2) 890-7



33 47-53






2010 2 303-330












References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

163



Cairo 1988 130





















218-227

References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

164














2008 43 201ndash209



Chemistry 2004 84 457-461







References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

165












2005








Exp Ther 1989 250 809-17




References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

166







64(3) 28-35




2004 5 545-552













References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

167





1984 327(1) 1-5





147-162






edition





Cel Bio 1999 1 60-67




References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

168


142-146






406-410





2(6) 701-704





5(16) 3697-3701






References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

169


D 1970 804-805


Hepatol 1996 8(12) 1227-1231





453-457


edition New York





254



16 6791-6805




Med Chem 1992 35 2735-2743


References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

170

CRC Press Boca 1999



4(10) 3439-3441





Kathmandu 1985















References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

171




Menopause 2012 19(12) 1336-46
















1975


Senses 1992 17 27-35


Rev Drug Dis 2005 4 206-220



New Delhi 2003

References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

172



240-249





Research 2002 45 469-473





965-972












References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

173











211-215






Research 2011 3(3) 31-57


517-33


69



References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

174








2006 4 71-76



Psychiatry 1998 44 1229-1238





1997 170 205-08








References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

175









882-885




Res 2007 184 142-149






50 796-805





References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

176



1997











Sciences 2010 1(4) 117-123










References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

177



Toxicology 2011 2(3) 119-122










26(41) 10387-10396











References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

178











4 48-53






2005 3 183-187







References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

179













278-280






432




research 1999 13(5) 448-450

References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

180







period 1981-2002 J Nat Prod 2003 66 1022-1037

















References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

181







505-511




2000b 73 233-245













References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

182
























References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

183


348







J Neurology 2004 11 734-741













Delhi 2006 2 578


References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

184


Resour 2012 2(1) 81-88






of India 2007-2008 6 (2)


23-26









Delhi India1990





References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

185









Biobehav Rev 1997 21(6) 801-810










6766-6774





References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

186










edition Sweden





399-407










References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

187





















98-101



References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

188

















edition






100-113


References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

189


22 2489-2503













331









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

190









report 1999 10(14) 3003-3007





1993 107 770-785





152



337-344


References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

191







205



2012 2(2) 163-168














References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

192








913-922



15 283-286













References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

193


FL 1999 1-16










188-197











1020

References

194





Nat Prod 2001 64 265-277














References

195









References

194





Nat Prod 2001 64 265-277














References

195









References

195









Documents

References - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/21736/15/15_bibliography.pdf · References 152 prefrontal cortex and amygdala. Behav.Brain Res 2009; 203(2): 279-287